EFCC Arraigns Moonlink Pharma MD for Alleged ₦55m Money Laundering, Court Orders Remand
The EFCC has arraigned Gabriel Celestine Nwawuzor, Managing Director of Moonlink Pharmaceuticals Limited, before the Federal High Court in Lagos over an alleged ₦55 million money-laundering scheme. Prosecutors accused him of diverting illicit funds through a Zenith Bank account in 2021 and disguising the money by purchasing a property in Asaba. Nwawuzor pleaded not guilty, but Justice Daniel Osiagor granted him ₦100 million bail with strict conditions, including two property-owning sureties. He was remanded in the correctional facility pending fulfilment of the bail terms. Trial begins March 11–12, 2026.
The EFCC has arraigned Gabriel Celestine Nwawuzor, Managing Director of Moonlink Pharmaceuticals Limited, before the Federal High Court in Lagos over an alleged ₦55 million money-laundering scheme. Prosecutors accused him of diverting illicit funds through a Zenith Bank account in 2021 and disguising the money by purchasing a property in Asaba. Nwawuzor pleaded not guilty, but Justice Daniel Osiagor granted him ₦100 million bail with strict conditions, including two property-owning sureties. He was remanded in the correctional facility pending fulfilment of the bail terms. Trial begins March 11–12, 2026.
EFCC Arraigns Moonlink Pharma MD for Alleged ₦55m Money Laundering, Court Orders Remand
The EFCC has arraigned Gabriel Celestine Nwawuzor, Managing Director of Moonlink Pharmaceuticals Limited, before the Federal High Court in Lagos over an alleged ₦55 million money-laundering scheme. Prosecutors accused him of diverting illicit funds through a Zenith Bank account in 2021 and disguising the money by purchasing a property in Asaba. Nwawuzor pleaded not guilty, but Justice Daniel Osiagor granted him ₦100 million bail with strict conditions, including two property-owning sureties. He was remanded in the correctional facility pending fulfilment of the bail terms. Trial begins March 11–12, 2026.
0 Comments
·0 Shares
·326 Views
